-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

Benzinga·12/18/2025 12:59:51
語音播報
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.